-+ 0.00%
-+ 0.00%
-+ 0.00%

Adagene, City of Hope Launch Phase 1 Trial of Colorectal Cancer Combination Therapy

PUBT·11/17/2026 13:02:34
Listen to the news
Adagene, City of Hope Launch Phase 1 Trial of Colorectal Cancer Combination Therapy
  • Adagene and City of Hope launched a Phase 1 trial of ivonescimab with muzastotug (ADG126) for advanced microsatellite-stable colorectal cancer.
  • The study will enroll up to 36 patients whose cancer progressed on prior systemic therapy.
  • Researchers will evaluate safety and preliminary antitumor activity to identify an optimal dose; benefits remain to be established.
  • Later stages will add chemotherapy to explore the combination as maintenance therapy and an earlier treatment option.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagene Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-128842), on November 17, 2026, and is solely responsible for the information contained therein.